InnoCan Pharma Corporation (CSE:INNO)
Canada · Delayed Price · Currency is CAD 2.200
-0.300 (-12.00%)
Aug 10, 2026, 2:15 PM EST
InnoCan Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -1.51 | -1.12 | -1.83 | -4.7 | -3.76 | -10.05 |
Depreciation & Amortization | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 |
Stock-Based Compensation | 1.94 | 1.46 | 2.01 | 0.85 | 0.97 | 2.16 |
Other Operating Activities | -2.41 | -1.46 | -0.51 | 0.7 | -2.77 | 2.18 |
Change in Accounts Receivable | - | - | 0.02 | -0 | -0.02 | 0 |
Change in Inventory | 0.77 | 1.14 | -1.57 | -0.62 | -0.62 | -0.08 |
Change in Accounts Payable | 0.15 | 0.05 | 0.07 | 0.02 | 0.04 | -0.47 |
Change in Other Net Operating Assets | 0.64 | 0.38 | 0.2 | -0.19 | 0.06 | -0.42 |
Operating Cash Flow | -0.38 | 0.5 | -1.58 | -3.9 | -6.07 | -6.63 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.01 | -0.02 | -0.02 | -0.05 | -0.03 | -0.04 |
Other Investing Activities | - | 0 | 0.07 | -0.04 | -0.01 | -0.01 |
Investing Cash Flow | -0.01 | -0.02 | 0.05 | -0.08 | -0.03 | -0.05 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 0.64 | - | - | - | - |
Long-Term Debt Repaid | - | -0.01 | -0.02 | -0.02 | -0.01 | -0.04 |
Net Debt Issued (Repaid) | 0.44 | 0.63 | -0.02 | -0.02 | -0.01 | -0.04 |
Issuance of Common Stock | 0.09 | 0.09 | 0.89 | 1.56 | 0.14 | 11.92 |
Other Financing Activities | 0.06 | 0.42 | 1.84 | 1.38 | - | 3.43 |
Financing Cash Flow | 0.6 | 1.15 | 2.7 | 2.92 | 0.13 | 15.3 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.05 | 0.05 | -0.06 | 0.01 | -0.13 | 0.08 |
Net Cash Flow | 0.26 | 1.68 | 1.12 | -1.06 | -6.1 | 8.71 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.39 | 0.48 | -1.59 | -3.95 | -6.09 | -6.67 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -1.54% | 1.80% | -5.42% | -28.92% | -238.10% | -3403.06% |
Free Cash Flow Per Share | -0.09 | 0.11 | -0.37 | -1.00 | -1.59 | -1.93 |
Levered Free Cash Flow | -0.53 | 0.22 | -0.22 | -0.72 | -6.25 | -7.41 |
Unlevered Free Cash Flow | -0.52 | 0.23 | -0.22 | -0.72 | -6.24 | -7.4 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 1.35 | 1.3 | 1.1 | - | - | - |
Change in Working Capital | 1.56 | 1.57 | -1.28 | -0.79 | -0.53 | -0.97 |